Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Actually my comment was not directed at the swing trading, but at the waiting for a binary event.
Volume has completely dried up.
I would not trade NWBO for a 20 or 30 cents swing. Not worth it. We are waiting for a binary event so we sit and wait.
Like I said, "It's in the eye of the beholder."
Anders, you underscore my point by referring to TA, as an art rather than a science. That is really code for "its all in the eye of the beholder," and not very rigorous. In any case if you keep on predicting that the chart will turn up (down) eventually it will happen, but that is not very helpful. It is like the broken clock that is right twice a day.
the SP has a choice to make
I think we are on the same page here. I am not 100% convinced, but so far as I can tell it's at least as good as any other theory I have seen and perhaps better.
I do not know if your theory is true or not, but it is certainly logical and very much a really possible explanation. To truely know, we will just have to let time play itself out.
OS against historical controls is NOT a gold standard.
"caboom" - is that yet another version "esco"??
So how does Merck or any other entity justify this valuation to their shareholders?
No wildtype here!
maybe ASSMO?
Scotty, it's ASCO or ESMO, there is no esco!
and instead an external event/agency stepped in to make them delay.
I am not looking for a lecture on slander and defamation, just trying to make a point about the exactness your post seemed to convey.
Anders, you can give a general description of the tort of defamation, but you can not blithely state the elements of defamation or slander without first referencing what jurisdiction you are talking about as the details may well differ from jurisdiction to jurisdiction, even if there may be similarity from one to the other.
Your rhetoric and your actions are totally incongruent!
so why are you buying??
How could they miss with naked shorting going on!
Anyone know the elevation at Sawston? If we are on high ground, we should be safe from flooding.
I have seen many references to Inmune on this BB, and I know it is another of LP's babies, but I never really investigated it or did any DD on it. It sounds like some of you think it may be a worthwhile investment. Can I ask for an Inmune 101 quick revue of the basics on what they do to start me off on my DD. Thanks
I will watch for that when I continue listening to the video - thanks.
Of course I am "with us." Where else would I be be. I am a long of "long standing." I have a significant holding in NWBO, both shares and warrants.
I have started listening to the video you suggested, but have not yet completed all of due to the pressures of time, and I agree with the points you make, however, from what I have seen so far I had one major disappointment. They point out how dire the situations is in the GBM research area and lack of any really helpful treatment and bemoan the situation in GBM.
But not once do they point to something potentially new on the horizon about to be revealed that may greatly change the lack of success to date. It is as thought they never heard of the PIII about to reveal itself, or do not believe it can succeed. I would have thought that this potential on the horizon in GBM would be the first thing they would point out - even if not quite certain yet - and at least hope for the potential in the very near and approaching future.
If you run a randomized trial, you want the people who take the drug to live longer than the people who did not. If they fail to, then the trial failed.
I do acknowledge that if the ITT arms show that OS was significantly better than placebo this could well be a win even if the trial technically failed for many of the possible reasons.
Yup, those were the days. To entice you to buy, thye would cut open a grapefruit while you stood there and offered a taste. Of course, they were really tasty and really sweet. They were very effective sales people - but they had a great product.
I used to live in Dallas many moons ago. I still remember those ruby Red - so delicious. They used to come around in pick-ups and sell them to you on the street in front of your house - fresh from the farmer!
Just filled at $1.22
With any luck, they will have a few bomblets on the way to the BOMB!
I was under the impression that there is very little institutional holdings in NWBO.
I would hate to think there is no catalyst between now and say mid September/October. that would mean more downward pressure on the price until then. LP seems not to care about the share price UNLESS it affects her or NWBO for financings. So assuming they have no need to raise funds before say Nov for the start of the M$ monthly repayments they can let the stock price drift continue downward for the near term. I hope that the PR on the completion of Sawston work, can buoy share price some, when that happens. Personally I hope the TLD will happen sooner, rather than later, perhaps Aug/Sept Well we will see what happens over the next eight - ten weeks. Sojo, any predictions on how this thing goes barring any surprise PRs? I do not really take your predictions as gospel (neither do you) but they are fun to watch, and there are no other tea leaves to read at the moment.
Well, I guess, we will all have to sit back and wait to see just how NWBO will choose to write up the BLA in terms of what they try to get approval for and whether they use the new or old definitions of GBM, and how eventually the FDA chooses to respond should they approve, and what terminology they will use on their labels.
They can’t license a product based upon an outdated notion of GBM.
OK, how you read or misread what I posted should not be the issue here. All I meant to say was that the redefining by the WHO of GBM, should be neither here nor there in regards to the success or failure of the PIII trial. It should stand or fall on what it intended to show and what was actually found about those in the trial. Any latter day relabeling should have no effect on the outcome of the trial either way. It would be like doing some gravity testing on Pluto before it was reclassified not to be a planet. The relabel should not affect the trial. So if someone was admitted to the trial under its stated terms, the fact that he was now relabeled to some other disease, other than GBM, should bot change anything. This has nothing to do with NWBO trying to do anything. The only thing that happened, was that in some distant land, a new label definition was being applied to some who happened to be in the NWBO trial. This should leave the trial totally unchanged and should succeed or fail on its own terms.
Even as you quote (some of) my words, you put your own spin on them and do not understand what I said.
I did no such thing!
My point is about the new definition, where it comes from and how your use of it to criticize the company makes little sense factually. Sorry if that disagreement on the logic and basic facts upsets you. But the details are not up for debate, so you’ve turned it into a personal issue.
Just because you say you "didn't doesn't mean you didn't.
I hear you